Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400086457Phase 4Not yet recruiting
Phase 4, randomised trial of ropivacaine, epinephrine, dexamethasone, magnesium sulfate and sodium bicarbonate in liver cancer, pancreatic cancer (PC), gallbladder cancer and 1 more (2 arms), sponsored by Chengdu Shangjin Nanfu Hospital. Primary endpoint: Postoperative administration of rescue analgesics within 24 hours. Planned start Jul 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400086457.